Single-agent high-dose melphalan followed by peripheral blood stem cell (PBSC) in lymphoma patients: An effective, and well-tolerated conditioning regimen [2]

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1067-1068
Number of pages2
JournalBone Marrow Transplantation
Volume33
Issue number10
DOIs
Publication statusPublished - May 2004

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this